$0.87
Price
$241M
Market Cap
—
P/E Ratio
-4.3
Forward P/E
$-0.12
EPS (TTM)
—
Dividend Yield
$156M
Cash
$52M
Total Debt
277M
Shares Out
$0.82
$3.34
52-Week Range
Institutional Ownership of Akebia Therapeutics Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Akebia Therapeutics Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2020-Q4 | |||||
| SELL | EXIT | — | — | $2.95 | |
| 2020-Q3 | |||||
| SELL | EXIT | — | — | $10.63 | |
| 2020-Q2 | |||||
| SELL | -14.4% | 15.0M | $204M | $11.64 | |
| 2020-Q1 | |||||
| SELL | -10.4% | 17.5M | $133M | $7.88 | |
| 2019-Q4 | |||||
| SELL | -20.0% | 19.6M | $124M | $4.15 | |
| 2018-Q4 | |||||
| BUY | NEW | 24.5M | $135M | $8.07 | |
| BUY | +405.4% | 5.7M | $31M | $8.07 | |
| 2018-Q3 | |||||
| BUY | NEW | 1.1M | $10M | $8.38 | |
Insider Trading for Akebia Therapeutics Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.